Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
Herzschrittmachertherapie & Elektrophysiologie|June 5, 2015
[ICD therapy in the primary prevention of sudden cardiac death: Risk stratification and patient selection]J Neuzner, R GradausEuropean Journal of Clinical Pharmacology|January 1, 1985
Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in manA Wellstein, D Palm, H F Pitschner, et al.Arzneimittel-Forschung|January 1, 1985
Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockersA Wellstein, D Palm, G G Belz, et al.Zeitschrift Fur Kardiologie|December 1, 1996
[The new potassium channel blocker tedisamil and its hemodynamic, anti-ischemic and neurohumoral effect in patients with coronary heart disease]V Mitrovic, E Oehm, R Strasser, et al.Life Sciences|January 1, 1989
AF-DX 116 discriminates heart from gland M2-cholinoceptors in manH F Pitschner, B Schulte, M Schlepper, et al.The American Journal of Cardiology|November 21, 2000
Pacemaker automaticityJ Neuzner, T Schwarz, J SperzelCardiology|June 9, 2000
Cold pressure test producing coronary spasm, coronary thrombosis and myocardial infarction in a patient with IgM antibodies against Coxsackie B virusW Haberbosch, N Roerich, J NeuznerBasic Research in Cardiology|March 1, 1993
Down-regulated beta-adrenoceptors in severely failing human ventricles: uniform regional distribution, but no increased internalizationH F Pitschner, A Droege, M Mitze, et al.Trends in Pharmacological Sciences|December 1, 1989
Selective antagonists reveal different functions of M cholinoceptor subtypes in humansH F Pitschner, M Schlepper, B Schulte, et al.Pageof 10